1,5-anhydroglucitol has been researched along with Diabetic Nephropathies in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, Y; Song, Y; Wang, Y; Yang, R | 1 |
Padilha, K; Pereira, AC; Rhee, EP; Tavares, G; Thadhani, RI; Titan, SMO; Venturini, G; Zatz, R | 1 |
Koga, M | 1 |
Hasslacher, C; Kulozik, F | 1 |
Egawa, S; Gu, Y; Inoue, K; Matsuno, S; Qi, M; Sakata, N; Sumi, S; Sunamura, M; Unno, M; Yamamoto, C | 1 |
Akanuma, Y | 1 |
Pitkänen, E; Servo, C | 1 |
Emoto, M; Inoue, T; Morii, H; Nishizawa, Y; Tabata, T | 1 |
2 review(s) available for 1,5-anhydroglucitol and Diabetic Nephropathies
Article | Year |
---|---|
1,5-Anhydroglucitol and glycated albumin in glycemia.
Topics: Anemia; Animals; Blood Glucose; Deoxyglucose; Diabetic Nephropathies; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperuricemia; Liver Cirrhosis; Serum Albumin | 2014 |
[Physiopathology and therapy of diabetes mellitus].
Topics: Animals; Arteriosclerosis; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Insulin Resistance; Obesity; Patient Education as Topic | 1999 |
1 trial(s) available for 1,5-anhydroglucitol and Diabetic Nephropathies
Article | Year |
---|---|
1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics.
Topics: Albuminuria; Biomarkers; Brazil; Creatinine; Deoxyglucose; Diabetic Nephropathies; Double-Blind Method; Gas Chromatography-Mass Spectrometry; Humans; Metabolomics | 2018 |
5 other study(ies) available for 1,5-anhydroglucitol and Diabetic Nephropathies
Article | Year |
---|---|
Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
Topics: Adult; Aged; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Uric Acid | 2019 |
Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
Topics: Aged; Albuminuria; Alpha-Globulins; Biomarkers; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Regression Analysis; Renal Insufficiency, Chronic; Serum Albumin; Severity of Illness Index | 2016 |
Hyperglycemia and diabetic renal change in a model of polyvinyl alcohol bioartificial pancreas transplantation.
Topics: Animals; Bioartificial Organs; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gels; Glomerular Mesangium; Hyperglycemia; Insulin; Islets of Langerhans; Kidney Function Tests; Linear Models; Male; Mice; Mice, Inbred C57BL; Pancreas Transplantation; Pancreas, Artificial; Polyvinyl Alcohol; Rats; Rats, Wistar; Severity of Illness Index; Time Factors; Tissue Culture Techniques; Tissue Engineering; Transplantation, Heterologous | 2007 |
Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients.
Topics: Aged; Blood Glucose; Creatinine; Deoxyglucose; Diabetes Mellitus; Diabetic Nephropathies; Ethers, Cyclic; Glucose; Humans; Inositol; Insulin; Middle Aged; Sorbitol; Sugar Alcohols; Uremia | 1975 |
Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
Topics: Adult; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis | 1992 |